Join ConQuest 2025 | ComplianceQuest User Conference | April 8–10, Clearwater Beach, FL
Discover your potential savings with our ROI Calculator
Middle Office Platform
The only AI-powered Middle Office Platform that unifies PLM, QMS, EHS, and SRM into a single, intelligent solution
Product Lifecycle Management
Enable cross-functional collaboration and accelerate your product lifecycle with a cloud-based platform for innovation
Design Process and Quality System Development Tools in Product Lifecycle
Design Quality
Get full visibility over your product design processes and make collaboration easy to get your products to market faster, compliantly
Design Quality: Connecting Design to Documentation
Complaints Management
Transform customer complaints to valuable sources of insights for continuous improvement through smart automations and integrated regulatory reporting
Challenges with Triage and Investigation in Complaints Management Process
Document and Learning Management
Say goodbye to paper! Modernize your processes with connected document, training, and change management
Manufacturing Challenges and Industry Trends Towards Digital Transformation
Quality Management
Transform quality into an enabler: boost efficiency, increase satisfaction, and trim costs with a fully connected, AI-powered quality management solution
Frost Radar for Quality Management Systems Names ComplianceQuest Leader
Risk Management
Enable risk-based thinking throughout your quality processes with a fully integrated risk management solution
Automation of the Risk Management Lifecycle with AI and Analytics
Supplier Management
Increase supplier performance, reduce costs, and streamline your supply chain with integrated supplier quality and collaboration tools
The Ultimate Guide to Next-Generation Supplier Management [e-Book]
Safety Management
Identify and minimize safety events. Prevent accidents, safeguard workers, and ensure their well-being and health
Safety Essentials: Key ‘Must-have’ Components for Safety Management at Any Enterprise
Environment and Sustainability
Proactively and accurately monitor and measure your company’s impact on the environment to improve performance and reach your environmental and sustainability targets
Environmental & Sustainability Management
Self-guided Product Tours
Product Demo Videos
Pricing
ComplianceQuest covers the whole spectrum of customers, industries and regions across the world. Whether it is a small, medium or enterprise sized manufacturer, companies choose ComplianceQuest for its end-to-end Product Lifecycle, Quality, Safety and Supplier Management Solutions.
Salesforce
Leveraging AI to Create a Safer Workplace Environment
Why an EHS Solution Built on Salesforce Works Better Than One Built on AWS or Azure
CQ Platform
Humans: The Real Superheroes of Artificial Intelligence (AI) in Quality Management
Recent Blogs
Recent Infographics
Recent Case Studies
Featured Case Study
ComplianceQuest Medical Devices QMS Success Stories eBook
Recent Checklists
Featured Checklist
Complaint Handling Process for MedTech and Life Science Companies
Course Offerings
Recent CQ Guides
Featured CQ Guide
Datasheets
Brochures
Demo Center
Podcasts
Podcast
Aphria (now Tilray) CIO talks about their implementation of ComplianceQuest, Rootstock and Salesforce
Videos
Recent Webinars
Webinar
Unlocking the Value of Complaints
Recent Whitepapers
Whitepaper
Why You Need to Digitally Transform Your QMS
Recent Compliance
Compliance
The Ultimate Guide to ISO/IEC 17025:2017 Compliance
Infographic
Safety Technology Trends to Watch in 2023 (Infographic)
Recent Toolkits
Featured Toolkit
Data-driven Safety – Strategic Resources for Monitoring of Key Performance Indicators
Events and Webinars
Events
Upcoming Webinars
Featured Event
Safety 2025 Conference & Expo
22 Jul, 2025
Orlando, FL
About
About ComplianceQuest
Transform to a fully connected business with a next-generation AI-powered Product Lifecycle, Quality, Safety, and Supplier management platform, built on Salesforce.
Our connected suite of solutions helps businesses of all sizes increase quality, safety and efficiency as they bring their products from concept to customer success.
Meet the Leadership Team
Careers
Where Your Career Takes Flight: Join our dynamic team and be part of an innovative, collaborative and rewarding workplace culture.
Corporate Citizenship
Impact Through Action: How the ComplianceQuest team supports social causes and community engagement
Customers & Testimonials
Newsroom
The Pulse of ComplianceQuest: Our newsroom shares stories of innovation, progress, and change
Partners
Stronger Together: How our partnerships drive success and innovation
Upcoming Events
Earlier this year, the Food and Drug Administration (FDA) decided to bring greater alignment between its medical device Quality System Regulation (QSR) and best practices stipulated in the ISO 13485 standard.
While this rule was first proposed in May 2018, it has now become a requirement and quality leaders are certainly happy about it. This alignment and harmonization by the FDA make global compliance easier overall– thanks to the greater correlation between compliance rules in various markets including the EU, Australia, and Japan.
FDA issues warning letters when products do not comply with certain statutory requirements. Upon receiving a warning letter from the FDA (which explains the violation with clarity), a manufacturer must outline the response plan and provide a rough timeline to complete a CAPA process, implement both corrective and preventive actions and submit relevant documentation to the FDA.
Quality and regulatory affairs (RA) leaders know that an FDA warning must be addressed with agility and effectiveness – the problem that caused the violation must be addressed, relevant documentation must be submitted back to the FDA and similar issues must be avoided in the future. This requires deep collaboration between multiple stakeholders and a data-driven process to arrive at what caused the violation.
All of this is often documented in the CAPA report, which also needs to be submitted to the FDA.
A CAPA report is the documentation of the actions taken to address the issue by gathering information, improving the QMS process, and implementing action plans with agility.
The document must be clear enough for the FDA reviewer to understand what specific actions have been taken.
Let’s discuss some of the key steps needed in addressing an FDA warning letter:
Step #1: Review the Warning Letter ThoroughlyAfter receiving an FDA Warning Letter, you should review the letter thoroughly as it’s important to know what and why the FDA is saying, the nature of the violation, and what type of response and actions the FDA is requesting.
Step #2: Conduct an Internal InvestigationOnce you review the Warning Letter, you must conduct an internal investigation under the oversight of a legal advisor. There are two very different responses that the investigation should seek including:
1. Either validate or deny the FDA’s allegations
2. Disclose the reasons for the alleged violations (if the investigation confirms the FDA’s allegations)
The company’s response plan must be decided once the internal audit and investigation is complete.
Step #3: Define an Initial Response to the FDAThis step is critical. The medical device manufacturer should work with a legal advisor to draft an appropriate written response due to the legal implications including the potential for enforcement action.
Step #4: Respond within the Deadline Indicated in the Warning LetterThe manufacturer must respond within the deadline indicated in the Warning Letter, regardless of how much information they can reveal between the receipt of the Warning Letter and the FDA’s response deadline. Otherwise, failure to adequately address the FDA’s Warning Letters completely within the deadline may result in legal action.
Step #5: Define Accurate Next StepsOnce the manufacturer provides the initial response to FDA, then they should focus on defining the next steps depending on the merit of the FDA’s allegations.
Step #6: Rectify Any Misguided ConclusionsIf a manufacturer disputes the allegations in an FDA Warning Letter, it is advisable for them to try to work with the FDA instead of working against them. The manufacturer should elaborate on why the FDA’s Warning Letter is misguided in a polite and non-aggressive way so that further inquiry or enforcement activity can be prevented.
Step #7: Take Further Preventive ActionIf the FDA’s conclusions are not misguided, then the manufacturer should focus on taking any further necessary action depending on the nature and scope of the issues.
Step #8: Take Internal Corrective ActionManufacturers should take essential corrective actions to address compliance deficiencies identified in FDA Warning Letters. Thus, you can reassess and update the manufacturer’s FDA compliance program.
Step #9: Evaluate Any Possible Risk for Enforcement ActionA manufacturer’s response to a Warning Letter prevents FDA from enforcing a penalty. But this does not mean that the manufacturer is protected from the liability of correcting the deficiencies identified in the letter. The legislation on consumer protection and violations of the FDCA (Federal Food, Drug, and Cosmetic Act) can result in private civil lawsuits.
Step #10: Gather a Defence StrategyThe manufacturer must work with their legal advisor to gather a comprehensive and cohesive defense strategy if the allegations underlying an FDA Warning Letter present a risk for civil or criminal litigation. Executing a dynamic defense strategy can significantly reduce the risks involved. Additionally, FDCA and other legal infringements can create substantial liability exposure.
With ComplianceQuest EQMS, it becomes easy for various stakeholders and departments to collaborate and respond to the FDA Warning letter. This includes automation of various processes to be completed after a warning letter has been received including internal audit and investigation, CAPA and Root Cause Analysis, submission of the FDA response and CAPA report, etc.
With CQ EQMS, quality and RA leaders are able to streamline the following:
To request a demo, visit: https://www.compliancequest.com/online-demo/
Learn about all features of our Product, Quality, Safety, and Supplier suites. Please fill the form below to access our comprehensive Demo Video.
Please confirm your details
By submitting this form you agree that we can store and process your personal data as per our Privacy Statement. We will never sell your personal information to any third party.
Enter Captcha
In 2018, the US FDA had announced its plans to harmonize FDA Quality System Regulations…
Laboratory-Developed Tests (LDTs) were initially governed by the Medical Device Amendments of 1976, and the…
According to FDA 21 CFR Part 820.70(i), any software used to automate any part of…